NDC 70510-2201

Exservan

Riluzole

Exservan is a Oral Film in the Human Prescription Drug category. It is labeled and distributed by Mitsubishi Tanabe Pharma America, Inc.. The primary component is Riluzole.

Product ID70510-2201_020ac44c-d66d-4785-8d7f-f8bb9051d61a
NDC70510-2201
Product TypeHuman Prescription Drug
Proprietary NameExservan
Generic NameRiluzole
Dosage FormFilm
Route of AdministrationORAL
Marketing Start Date2021-05-01
Marketing CategoryNDA /
Application NumberNDA212640
Labeler NameMitsubishi Tanabe Pharma America, Inc.
Substance NameRILUZOLE
Active Ingredient Strength50 mg/1
Pharm ClassesBenzothiazole [EPC],Benzothiazoles [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70510-2201-2

60 POUCH in 1 CARTON (70510-2201-2) > 1 FILM in 1 POUCH (70510-2201-1)
Marketing Start Date2021-05-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Exservan" or generic name "Riluzole"

NDCBrand NameGeneric Name
10094-350EXSERVANriluzole
70510-2201Exservanriluzole
70510-2202Exservanriluzole
70515-700Rilutekriluzole
0378-4145Riluzoleriluzole
42291-775Riluzoleriluzole
60505-3285RILUZOLERILUZOLE
62756-538RiluzoleRiluzole
64980-191Riluzoleriluzole
67877-286RiluzoleRiluzole
68084-908RILUZOLERILUZOLE
68462-381riluzoleriluzole
69076-200Riluzoleriluzole
69076-611RiluzoleRiluzole
70726-0303TIGLUTIKRiluzole

Trademark Results [Exservan]

Mark Image

Registration | Serial
Company
Trademark
Application Date
EXSERVAN
EXSERVAN
90792818 not registered Live/Pending
Aquestive Therapeutics, Inc.
2021-06-24
EXSERVAN
EXSERVAN
90303402 not registered Live/Pending
AQUESTIVE THERAPEUTICS, INC.
2020-11-06
EXSERVAN
EXSERVAN
87512075 not registered Live/Pending
AQUESTIVE THERAPEUTICS, INC.
2017-06-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.